Search results for " ALZHEIMER"

showing 9 items of 149 documents

Weight loss in Alzheimer’s disease, vascular dementia and dementia with Lewy bodies: Impact on mortality and hospitalization by dementia subtype

2021

Objectives Loss of weight is associated with cognitive decline as well as several adverse outcomes in dementia. The aim of this study was to assess whether weight loss is associated with mortality and hospitalization in dementia subtypes. Methods A cohort of 11,607 patients with dementia in Alzheimer's disease (AD), vascular dementia (VD), or dementia with Lewy bodies (DLB) was assembled from a large dementia care health records database in Southeast London. A natural language processing algorithm was developed to established whether loss of weight was recorded around the time of dementia diagnosis. Cox proportional hazard models were applied to examine the associations of reported weight l…

medicine.medical_specialtyWeight lossInternal medicinemental disordersmedicineDementiaCognitive declineVascular dementiaImpact on mortality and hospitalization by dementia subtype.- International journal of geriatric psychiatry 2021 [Soysal P. Tan S. G. Rogowska M. Jawad S. Smith L. Veronese N. Tsiptsios D. Tsamakis K. Stewart R. Mueller C. -Weight loss in Alzheimer-s disease vascular dementia and dementia with Lewy bodies]Dementia with Lewy bodiesbusiness.industryAlzheimer's disease dementia hospitalization Lewy bodies mortality weight lossHazard ratioAlzheimer's diseasemedicine.diseasemortalityConfidence intervalPsychiatry and Mental healthCohortGeriatrics and Gerontologymedicine.symptomweight lossbusinessLewy bodiesdementiahospitalization
researchProduct

CHF2819: Pharmacological profile of a novel acetylcholinesterase inhibitor

2002

CHF2819 is a novel orally active acetylcholinesterase inhibitor (AChEI) developed for the treatment of Alzheimer's disease (AD). CHF2819 is a selective inhibitor of AChE, it is 115 times more potent against this enzyme than against butyrylcholinesterase (BuChE). Moreover, CHF2819 is more selective for inhibition of central (brain) AChE than peripheral (heart) AChE. In vivo CHF2819, 0.5, 1.5, and 4.5 mg/kg p.o., significantly and in dose-dependent manner increased acetylcholine (ACh) levels in hippocampus of young adult rats. Moreover, aging animals, with lower basal ACh levels than young adult rats, also exhibit a marked increase in hippocampal levels of this neurotransmitter after administ…

medicine.medical_specialtymedicine.drug_classPhenylcarbamatesPharmacologyHippocampusArticleCyclic N-Oxideschemistry.chemical_compoundNeurochemicalAlzheimer DiseaseDopamineInternal medicinemedicineAnimalsBiogenic MonoaminesAmino AcidsNeurotransmitterButyrylcholinesteraseCholinesterasePharmacologybiologybusiness.industryGlutamate receptoracetylcholinesterase inhibitors; alzheimer's disease; amino acids; chf2819; ganstigmine; neurotransmitters; rat hippocampusAcetylcholineRatsNeuropsychology and Physiological PsychologyEndocrinologyAcetylcholinesterase inhibitorchemistrybiology.proteinCarbamatesCholinesterase InhibitorsbusinessAcetylcholinemedicine.drug
researchProduct

Preclinical phase of Alzheimer's disease: Guideline for recognition and study of patients with mild cognitive impairment

2002

mild cognitive impairment Alzheimer DiseaseSettore MED/26 - Neurologia
researchProduct

Conjugation strategies of insulin to nanogels: new hope for nanogels Alzheimer's disease therapy?

2014

nanogels Alzheimer's therapySettore CHIM/07 - Fondamenti Chimici Delle Tecnologie
researchProduct

Influencia de las emociones positivas en la salud de los cuidadores de enfermos de Alzheimer

2015

La Organización Mundial de la Salud define la salud como un estado de completo bienestar físico, mental y social, y no solamente la ausencia de afecciones o enfermedades. En la actualidad, las aproximaciones a los conceptos de salud/enfermedad son pluridimensionales y recogen aspectos bio-psico-sociales. Desde esta perspectiva, los cuidadores familiares de enfermos de Alzheimer pueden verse afectados en las tres dimensiones, ya que desempeñar la tarea de cuidador puede producir diversas repercusiones bio-psico-sociales. Muchos estudios han demostrado que la salud de los cuidadores familiares de enfermos de Alzheimer se ve perjudicada por el hecho de prestar los cuidados. El cuidador, experi…

psicología positiva:PSICOLOGÍA [UNESCO]Cuidadores familiares de enfermos de AlzheimerUNESCO::PSICOLOGÍAsalud física percibidasalud mental
researchProduct

Radiomics Analysis of Brain [18F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Appli…

2022

Background: Early in-vivo diagnosis of Alzheimer’s disease (AD) is crucial for accurate management of patients, in particular, to select subjects with mild cognitive impairment (MCI) that may evolve into AD, and to define other types of MCI non-AD patients. The application of artificial intelligence to functional brain [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography(CT) aiming to increase diagnostic accuracy in the diagnosis of AD is still undetermined. In this field, we propose a radiomics analysis on advanced imaging segmentation method Statistical Parametric Mapping (SPM)-based completed with a Machine-Learning (ML) application to predict the diagnosi…

radiomics; Alzheimer’s disease; PET/CT; machine learningAlzheimer’s disease; machine learning; PET/CT; radiomicsmachine learningPET/CTradiomicsradiomicClinical Biochemistryradiomics; Alzheimer's disease; PET/CT; machine learningAlzheimer’s diseaseDiagnostics
researchProduct

SOLID LIPID NANOPARTICLES CONTAINING AN ANTIOXIDANT COMPOUND IN ALZHEIMER’S DISEASE

2008

solid lipid nanoparticles drug delivery alzheimer's diseaseSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Il ruolo della corteccia prefrontale dorsolaterale nella memoria di riconoscimento: uso dellla Stimolazione Magnetica Transcranica per il trattamento…

Il ruolo della corteccia prefrontale dorsolaterale (DLPFC) in compiti di memoria è stato largamente documentato. Una questione ancora molto dibattuta è il grado di lateralizzazione anatomica-funzionale dei processi di controllo esecutivo della DLPFC coinvolti nella memoria di riconoscimento. Il lavoro di tesi indaga le connessioni tra DLPFC e ippocampo mediante l’applicazione di tecniche di neuromodulazione dell’eccitabilità della DLPFC che consentano di accrescere l’attività ippocampale durante compiti di memoria di riconoscimento. I primi tre studi valutano gli effetti inibitori ed eccitatori della rTMS applicata alla DLPFC sulla performance in compiti di memoria di riconoscimento, in div…

stimolazione magnetica transcranica (rTMS)neuromodulazionecorteccia prefrontale dorsolaterale (DLPFC)Alzheimer‘s disease (AD)Settore M-PSI/02 - Psicobiologia E Psicologia FisiologicaMild Cognitive Impairment (MCI)memoria di riconoscimento; corteccia prefrontale dorsolaterale (DLPFC); stimolazione magnetica transcranica (rTMS); encoding; retrieval; Mild Cognitive Impairment (MCI); Alzheimer‘s disease (AD); neuromodulazione;memoria di riconoscimentoencodingretrieval
researchProduct

Il contributo sociale delle superfici vetrate.

2014

Oggi la domanda abitativa è cambiata, non solo negli aspetti quantitativi ma soprattutto nella dimensione qualitativa. Nel tempo, in relazione a fenomeni di carattere sociale ancor prima che economico, sono cambiate le categorie sociali più deboli, ora rappresentate soprattutto dagli anziani. Inoltre, in relazione all’innalzamento della soglia di mortalità, si assiste a un progressivo e costante aumento dei casi di demenza senile, un disturbo delle funzioni intellettive in precedenza acquisite quali la memoria a breve e lungo termine, il pensiero astratto, la capacità critica, il linguaggio e l’orientamento spazio temporale. L’ampia e crescente diffusione nella popolazione, la limitata e co…

vetro luce anziani Alzheimer ambiente protesico comfortSettore ICAR/12 - Tecnologia Dell'Architettura
researchProduct